News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Retrophin, LLC to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference


2/5/2013 6:07:16 AM

Retrophin (OTCQB: RTRX), a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases, today announced that Martin Shkreli, Founder & Chief Executive Officer, will be presenting at the 15th Annual BIO CEO & Investor Conference, which is being held February 11-12 in New York, NY. Shkreli will provide corporate updates and discuss upcoming clinical milestones, including enrollment in a potentially pivotal Phase II clinical trial of Retrophin’s lead compound, RE-021.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES